Cite
HARVARD Citation
Qi, M. et al. (2023). Corrigendum to 'Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70′ [Pharmacol. Res. 100 (2015) 341–352]. Pharmacological research. p. . [Online].